Kinase Mutations as Predictive Biomarkers in Hematolymphoid Malignancies

Journal Title: Journal of Hematology & Thrombosis - Year 2015, Vol 1, Issue 1

Abstract

Targeted therapeutics against kinases has been employed in the clinic for over a decade. Their use of ten times requires concomitant molecular diagnostics evaluating the mutational status of the targeted kinases. While kinase mutations function as diagnostic and prognostic biomarkers in hematolymphoid malignancies, in this review, we focus on kinase mutations with predictive utility and their relevance to molecular diagnostics.

Authors and Affiliations

Benedict Yan

Keywords

Related Articles

The Promise and Challenges of Personalized Medicine in Hematologic Malignancies

Personalized medicine is a rapidly emerging medical model that proposes individually customized healthcare to potentially increase the quality of clinical care and reduce health care costs. The key to the success of pers...

The Application of Holotranscobalamin and Methylmalonic Acid in Hospital Patients and Total Vitamin B12 in Primary Care Patients to Assess Low Vitamin B12 Status

Background: Low vitamin B12 (B12) status is common in patient populations. The timely detection and correction of low B12 prevents megaloblastic anaemia and neurological impairment. However, prompt diagnosis is recognise...

Recombinant Human Soluble Thrombomodulin is Effective for Severe Childhood EBV-HLH

Hemophagocytic lymphohistiocytosis (HLH) is a fatal disease, presenting with T cell-induced dysregulated cytokine production, systemic inflammation, and frequently intractable coagulopathy. We have administered recombina...

Differences in Circulating Endothelial Progenitor Cells among Childhood Cancer Survivors Treated with and without Radiation

Radiation during childhood cancer treatment increases the propensity to atherosclerotic cardiovascular disease among adult survivors of childhood cancer. This is thought to be mediated through the damage to the underlyin...

Large Granular Lymphocytic Leukemia and Cocaine Abuse in A Patient With Chronic Neutropenia - Are They Co-Existing or Causally Related?

Chronic neutropenia is a hematological condition that could cause significant morbidity due to recurrent infections. Various benign and malignant disorders manifest with chronic neutropenia and a meticulous evaluation is...

Download PDF file
  • EP ID EP246384
  • DOI 10.13188/2380-6842.1000001
  • Views 119
  • Downloads 0

How To Cite

Benedict Yan (2015). Kinase Mutations as Predictive Biomarkers in Hematolymphoid Malignancies. Journal of Hematology & Thrombosis, 1(1), 1-4. https://europub.co.uk/articles/-A-246384